W. Rathmell
Last active: 11/27/2019

A Pilot Clinical Study in Characterization of Malignant Renal-cell Carcinoma Subtype with Contrast-enhanced Ultrasound.

Kasoji SK, Chang EH, Mullin LB, Chong WK, Rathmell WK, Dayton PA
Ultrason Imaging. 2017 39 (2): 126-136

PMID: 27659687 · PMCID: PMC5599099 · DOI:10.1177/0161734616666383

Malignant renal cell carcinoma (RCC) is a diverse set of diseases, which are independently difficult to characterize using conventional MRI and CT protocols due to low temporal resolution to study perfusion characteristics. Because different disease subtypes have different prognoses and involve varying treatment regimens, the ability to determine RCC subtype non-invasively is a clinical need. Contrast-enhanced ultrasound (CEUS) has been assessed as a tool to characterize kidney lesions based on qualitative and quantitative assessment of perfusion patterns, and we hypothesize that this technique might help differentiate disease subtypes. Twelve patients with RCC confirmed pathologically were imaged using contrast-enhanced ultrasound. Time intensity curves were generated and analyzed quantitatively using 10 characteristic metrics. Results showed that peak intensity ( p = 0.001) and time-to-80% on wash-out ( p = 0.004) provided significant differences between clear cell, papillary, and chromophobe RCC subtypes. These results suggest that CEUS may be a feasible test for characterizing RCC subtypes.

MeSH Terms (7)

Carcinoma, Renal Cell Contrast Media Diagnosis, Differential Fluorocarbons Humans Kidney Neoplasms Ultrasonography

Connections (1)

This publication is referenced by other Labnodes entities:

Links